Search research articles
Contact Us
Filters
Showing results (151-160 of 192) with videos related to
Page
of 20
Sort By:
Journal of Lipid Research
|
September 16, 2005
Peroxisome proliferator-activated receptor alpha controls cellular cholesterol trafficking in macrophages
G Chinetti-Gbaguidi, E Rigamonti, L Helin, et al.
Journal of Cardiovascular Pharmacology
|
August 7, 2001
Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice
F Dol, G Martin, B Staels, et al.
Circulation
|
May 11, 1999
Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response
N Hennuyer, P Poulain, L Madsen, et al.
The Journal of Clinical Investigation
|
June 1, 1996
Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
L Berthou, N Duverger, F Emmanuel, et al.
Journal of Lipid Research
|
December 20, 1999
Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation
E Raspé, L Madsen, A M Lefebvre, et al.
Annals of the New York Academy of Sciences
|
December 27, 1996
PPAR tissue distribution and interactions with other hormone-signaling pathways
T Lemberger, O Braissant, C Juge-Aubry, et al.
Biochemical Society Transactions
|
November 1, 2006
PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases
R Bordet, T Ouk, O Petrault, et al.
FEBS Letters
|
February 20, 2002
Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages
F G Gbaguidi, G Chinetti, D Milosavljevic, et al.
The Journal of Biological Chemistry
|
September 5, 1997
Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha
N Vu-Dac, P Gervois, T Grötzinger, et al.
Circulation
|
December 16, 1998
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha
A Mamontova, S Séguret-Macé, B Esposito, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 192) with videos related to
Sort By:
Page
of 20
Journal of Lipid Research
|
September 16, 2005
Peroxisome proliferator-activated receptor alpha controls cellular cholesterol trafficking in macrophages
G Chinetti-Gbaguidi, E Rigamonti, L Helin, et al.
Journal of Cardiovascular Pharmacology
|
August 7, 2001
Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice
F Dol, G Martin, B Staels, et al.
Circulation
|
May 11, 1999
Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response
N Hennuyer, P Poulain, L Madsen, et al.
The Journal of Clinical Investigation
|
June 1, 1996
Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
L Berthou, N Duverger, F Emmanuel, et al.
Journal of Lipid Research
|
December 20, 1999
Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation
E Raspé, L Madsen, A M Lefebvre, et al.
Annals of the New York Academy of Sciences
|
December 27, 1996
PPAR tissue distribution and interactions with other hormone-signaling pathways
T Lemberger, O Braissant, C Juge-Aubry, et al.
Biochemical Society Transactions
|
November 1, 2006
PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases
R Bordet, T Ouk, O Petrault, et al.
FEBS Letters
|
February 20, 2002
Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages
F G Gbaguidi, G Chinetti, D Milosavljevic, et al.
The Journal of Biological Chemistry
|
September 5, 1997
Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha
N Vu-Dac, P Gervois, T Grötzinger, et al.
Circulation
|
December 16, 1998
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha
A Mamontova, S Séguret-Macé, B Esposito, et al.
Page
of 20